NCT07187206招募中3 期
Safety and Efficacy of FETO in CDH Phase III
适应症
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 75
- 试验地点
- 1
- 主要终点
- Change lung growth on prenatal imaging
研究概览
简要总结
Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group
详细描述
The purpose of this study is to demonstrate that the FETO procedure increases the neonatal survival to discharge and reduces long-term morbidity rates in fetuses found to have intrathoracic herniation of the liver with LCDH and o/e LHR < 30% or RCDH and o/e LHR < 45 % with intrathoracic liver herniation when compared to those that receive standard of care management that have comparable defects for side and fetal lung volumes estimates and intrathoracic liver herniation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Pregnant women 18 years and older, who are able to consent
- •Singleton pregnancy
- •Gestational age at enrollment is prior to 296 weeks
- •Intrathoracic liver herniation
- •Isolated Left CDH with o/e LHR < 30% at enrollment (180 to 295 weeks) or
- •Isolated Right CDH with o/e LHR < 45% at enrollment (180 to 295 weeks)
- •Normal fetal karyotype with confirmation by culture results, CMA with non-pathological variants, WES or WGS. Results by fluorescence in situ hybridization (FISH) will be acceptable if the patient is > 26 weeks
- •Cervical length by transvaginal ultrasound > 20 mm within 24 hours prior to FETO procedure
- •Patient meets psychosocial criteria
- •Informed consent understood
排除标准
- •Patient < 18 years of age
- •Multi-fetal pregnancy
- •History of natural rubber latex allergy
- •Preterm labor, cervix shortened (< 20 mm at enrollment or within 24 hours prior to FETO balloon insertion) or uterine anomaly strongly predisposing to preterm labor, or placenta previa.
- •Psychosocial ineligibility, precluding consent:
- •Inability to reside within 30 minutes of Cincinnati Children's Hospital Medical Center and inability to comply with the travel for the follow-up requirements of the trial.
- •The patient does not have a support person (e.g. spouse, partner, mother) available to stay with the patient for the duration of the pregnancy at Cincinnati Children's Hospital Medical Center.
- •Bilateral CDH, isolated LCDH with o/e LHR ≥ 30%, isolated RCDH with o/e LHR > 45%, as determined by ultrasound.
- •No liver herniation into thoracic cavity
- •Additional fetal anomaly and chromosomal abnormalities, associated anomalies recognized to alter survival prognosis (i.e., congenital heart disease) or presence of an underlying genetic syndrome (i.e., Fryns) by ultrasound, MRI, or echocardiogram at the fetal treatment center.
- •Maternal contraindication to fetoscopic surgery or severe maternal medical condition in pregnancy
- •History of incompetent cervix with or without cerclage
- •Placental abnormalities (previa, abruption, accreta) known at time of enrollment
- •Maternal-fetal Rh isoimmunization, Kell sensitization or neonatal alloimmune thrombocytopenia affecting the current pregnancy
- •Maternal HIV, Hepatitis-B, Hepatitis-C positive because of the increased risk of transmission to the fetus during maternal-fetal surgery. If the patient's HIV status is unknown, the patient must be tested and found to have negative results before enrollment.
- •Positive Hepatitis B surface antigen or presence of Hepatitis C in maternal blood uterine anomaly such as Mullerian duct abnormality, large or multiple fibroids that prohibit safe fetoscopic procedure
- •There is no safe or technically feasible fetoscopic approach to balloon placement
- •Participation in another intervention study that influences maternal and fetal morbidity and mortality, or participation in this trial in a previous pregnancy
研究组 & 干预措施
Fetuses with severe or moderate congenital diaphragmatic hernia will be offered fetal tracheal occlu
Experimental
FETO balloon placement/removal
干预措施: FETO, Fetal Endoluminal Tracheal Occlusion (Device)
Fetuses with severe or moderate congenital diaphragmatic hernia will receive standard of care and op
No Intervention
no intervention standard of care
结局指标
主要结局
Change lung growth on prenatal imaging
时间窗: prenatal period up to 40 weeks gestation
Change in o/eLHR and other prenatal imaging tests
次要结局
- Change survival in the severe congenital diaphragmatic hernia subgroup in intervention group(6 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic HerniaHypertension PulmonaryPulmonary HypoplasiaCongenital Diaphragmatic HerniaNCT02986087Children's Hospital Medical Center, Cincinnati40
招募中
不适用
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDHCongenital Diaphragmatic HerniasNCT02530073Connecticut Children's Medical Center15
招募中
不适用
Fetal Endoscopic Tracheal Occlusion for CDH (CDH)Congenital Diaphragmatic HerniaNCT05421676University of California, Davis10
Unknown
不适用
FETO With Long Tail Balloon for a Treatment of Severe CDHSevere Congenital Diaphragmatic HerniaNCT03431792Martin-Luther-Universität Halle-Wittenberg20
招募中
不适用
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)Pulmonary Artery HypertensionCongenital Diaphragmatic HerniaPulmonary HypoplasiaNCT03138863Rodrigo Ruano10